SCHEMBL4450380

SCHEMBL4450380

CC(C)(C)CC(C)(C)c1ccc(OCCOC(C)(C)CCc2ccccc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.56
▸ KMT2A Q03164 4/20 0.56
▸ CYP3A4 P08684 3/20 0.56
▸ LMNA P02545 3/20 0.56
▸ TSHR P16473 3/20 0.56
▸ TDP1 Q9NUW8 3/20 0.56
▸ MEN1 O00255 3/20 0.56
▸ APAF1 O14727 3/20 0.56
▸ USP2 O75604 3/20 0.56
▸ ALDH1A1 P00352 3/20 0.56
▸ TP53 P04637 3/20 0.56
▸ MAPT P10636 3/20 0.56
▸ RAD52 P43351 3/20 0.56
▸ HIF1A Q16665 3/20 0.56
▸ ERBB2 P04626 2/20 0.56
▸ FYN P06241 2/20 0.56
▸ CHRM2 P08172 2/20 0.56
▸ CHRM4 P08173 2/20 0.56
▸ CHRM5 P08912 2/20 0.56
▸ ADRA2A P08913 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9822937 0.82 SMN1; SMN2 (0.59) SMN1; SMN2KMT2ACYP3A4LMNATSHR
SCHEMBL26657537 0.79 SMN1; SMN2 (0.67) SMN1; SMN2KMT2ACYP3A4LMNATSHR
Hydrochloric Acid SCHEMBL1934509 0.77 SMN1; SMN2 (0.59) SMN1; SMN2KMT2ACYP3A4LMNATSHR
SCHEMBL4288922 0.77 SMN1; SMN2 (0.53) SMN1; SMN2KMT2ACYP3A4LMNATSHR
SCHEMBL11057809 0.76 SMN1; SMN2 (0.57) SMN1; SMN2KMT2ACYP3A4LMNATSHR
Hydrochloric Acid SCHEMBL426560 0.76 KMT2A (0.60) SMN1; SMN2KMT2ACYP3A4LMNATSHR
Hydrochloric Acid SCHEMBL29999168 0.75 KMT2A (0.65) SMN1; SMN2KMT2ACYP3A4LMNATSHR
SCHEMBL19074259 0.75 LMNA (0.63) SMN1; SMN2KMT2ACYP3A4LMNATSHR
Hydrochloric Acid SCHEMBL2761472 0.74 LMNA (0.61) SMN1; SMN2KMT2ACYP3A4LMNATSHR
SCHEMBL5936853 0.74 KCNA3 (0.48) SMN1; SMN2KMT2ACYP3A4LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060197067-A1 Radiation-absorbing materials, ophthalmic compositions containing same, and method of treating ophthalmic devices BAUSCH & LOMB INCORPORATED 2006-09-07 — — US claimed
EP-1339418-B1 IMPROVED OPHTHALMIC AND CONTACT LENS SOLUTIONS CONTAINING SIMPLE SACCHARIDES AS PRESERVATIVE ENHANCERS FXS VENTURES LLC (US) 2009-09-23 — — EP disclosed
WO-2006096422-A1 RADIATION-ABSORBING MATERIALS, OPHTHALMIC COMPOSITIONS CONTAINING SAME, AND METHOD OF TREATING OPHTHALMIC DEVICES BAUSCH & LOMB INCORPORATED (US) 2006-09-14 — — WO disclosed
US-6793941-B1 HYDROGEN PEROXIDE-FREE OPHTHALMIC SOLUTION COMPRISED OF NATURALLY- OCCURRING MICROBICIDAL COMPOUND SELECTED FROM: ALLICIN, AUCUBIN, BILBERRY EXTRACT, CAFFEIC ACID, CHLOROGENIC ACID, FERULIC ACID, NARINGIN, OLEUROPEIN, AND RUTIN NATURAL DISINFECTANT TECHNOLOGIES, INC. (AN) 2004-09-21 — — US disclosed
EP-1102602-B1 CONTACT LENS AND OPHTHALMIC SOLUTIONS NDT INC (US) 2004-04-21 — — EP disclosed
EP-1102602-A1 CONTACT LENS AND OPHTHALMIC SOLUTIONS NDT, Inc. (US) 2001-05-30 — — EP disclosed
WO-2000007634-A1 CONTACT LENS AND OPHTHALMIC SOLUTIONS NDT, INC. (US) 2000-02-17 — — WO disclosed
US-4485176-A Turbidimetric method for measuring protein in urine and cerebrospinal fluid E. I. DU PONT DE NEMOURS & COMPANY (US) 1984-11-27 — — US disclosed
Send feedback